Books on the topic 'Myeloproliferative'

To see the other types of publications on this topic, follow the link: Myeloproliferative.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Myeloproliferative.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Melo, Junia V., and John M. Goldman. Myeloproliferative Disorders. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-34506-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Verstovsek, Srdan, and Ayalew Tefferi, eds. Myeloproliferative Neoplasms. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-266-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Barbui, Tiziano, and Ayalew Tefferi, eds. Myeloproliferative Neoplasms. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-24989-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Richard, Green A., and Pearson Tom C, eds. Myeloproliferative disorders. London: Baillière Tindall, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mesa, Ruben A., and Claire Harrison, eds. Managing Myeloproliferative Neoplasms. Cambridge: Cambridge University Press, 2016. http://dx.doi.org/10.1017/cbo9781316017852.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Myeloproliferative neoplasms: Biology and therapy. New York: Humana Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Petrides, Petro E., and Heike L. Pahl, eds. Molecular Basis of Chronic Myeloproliferative Disorders. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18738-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barbui, Tiziano. Myeloproliferative Neoplasms: Critical Concepts and Management. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Parker, James N., and Philip M. Parker. The official patient's sourcebook on myeloproliferative disorders. San Diego, Calif: Icon Health Publications, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dallinger, Kenneth James Charles. Myeloproliferative disorders: The effect on (1) fibrinogen turnover, (2) prostanoid metabolism. Birmingham: University of Birmingham, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Leukemia & Lymphoma Society of America. Coping: Support for people living with leukemia, lymphoma or myeloma. White Plains, N.Y.]: Leukemia & Lymphoma Society, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

D, Zanjani Esmail, Tavassoli Mehdi 1933-, Ascensao Joao L, and Wasserman Louis R, eds. Regulation of erythropoiesis. New York: PMA Pub. Corp., 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

McCormick, Thomas Ronald. A study of Beta-2-Microglobulin in myeloproliferative, lymphoproliferative and renal disorders. [S.l: The Author], 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Estella, Matutes, ed. Chronic myeloid leukaemias. Oxford: Clinical Pub., 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

H, Robinson Stephen, and Reich Paul Richard, eds. Hematology: Pathophysiologic basis for clinical practice. 3rd ed. Boston: Little, Brown, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Bergamo Spring Conferences on Haematology (1st 1987). Cellular blood components in haemostasis and thrombosis: Implications from myeloproliferative disorders : proceedings of the Conference held in Bergamo on May 7-8, 1987. London: Libbey, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Diagnostic techniques in hematological malignancies. Cambridge: Cambridge University Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

N, Emmons Foxwell, ed. Atlas of differential diagnosis in neoplastic hematopathology. 2nd ed. London: Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

G, Abraham Nader, and Symposium on the Molecular Biology of Hematopoiesis (11th 1998 : Bormio, Italy), eds. Molecular biology of hematopoiesis 6. New York: Kluwer Academic/Plenum Publishers, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Pathology of bone marrow. New York, N.Y: Igaku-Shoin, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Pathology of bone marrow. 2nd ed. Baltimore: Williams & Wilkins, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

1926-, Cacciola E., Deisseroth Albert B. 1941-, and Giustolisi R, eds. Hemopoietic growth factors, oncogenes, and cytokines in clinical hematology: Current aspects and future directions. Basel: Karger, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Wehrle, Julius. Genomweite Analyse der Regulation durch NF-E2 in hämatopoetischen Stammzellen im Kontext myeloproliferativer Neoplasien. [S.l: s.n.], 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Melo, J. V., and J. Goldman. Myeloproliferative Disorders. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Collins, Graham, and Chris Bunch. Myeloproliferative disorders. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0291.

Full text
Abstract:
Myeloproliferative disorders (also called myeloproliferative neoplasms) can be defined as clonal haematopoietic disorders resulting in excess production of one or more blood cell lineage. The four main conditions are primary polycythaemia, which is characterized by excess red-cell production; essential thrombocythaemia, which is characterized by excess platelet production; chronic myeloid leukaemia, which is characterized by excess granulocyte production; and myelofibrosis, which is characterized by excess megakaryocyte proliferation, which results in a reactive fibroblast proliferation causing marrow fibrosis and failure. This chapter addresses the causes, diagnosis, and management of these myeloproliferative disorders.
APA, Harvard, Vancouver, ISO, and other styles
26

Provan, Drew, Trevor Baglin, Inderjeet Dokal, and Johannes de Vos. Myeloproliferative neoplasms. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0007.

Full text
Abstract:
Myeloproliferative neoplasms (MPNs) - Pathogenesis of the MPNs - Polycythaemia vera (PV) - Natural history of PV - Management of PV - Secondary erythrocytosis - Relative erythrocytosis - Idiopathic erythrocytosis - Essential thrombocythaemia - Reactive thrombocytosis - Primary myelofibrosis - Chronic neutrophilic leukaemia - Eosinophilic syndromes and neoplasms - Mastocytosis (mast cell disease) - Systemic mastocytosis - MPN—unclassifiable
APA, Harvard, Vancouver, ISO, and other styles
27

Provan, Drew, Trevor Baglin, Inderjeet Dokal, Johannes de Vos, and Mammit Kaur. Myeloproliferative neoplasms. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199683307.003.0007_update_001.

Full text
Abstract:
Myeloproliferative neoplasms (MPNs) - Pathogenesis of the MPNs - Polycythaemia vera (PV) - Natural history of PV - Management of PV - Secondary erythrocytosis - Relative erythrocytosis - Idiopathic erythrocytosis - Essential thrombocythaemia - Reactive thrombocytosis - Primary myelofibrosis - Chronic neutrophilic leukaemia - Eosinophilic syndromes and neoplasms - Mastocytosis (mast cell disease) - Systemic mastocytosis - MPN—unclassifiable
APA, Harvard, Vancouver, ISO, and other styles
28

Silver, Richard T., and Ayalew Tefferi, eds. Myeloproliferative Disorders. CRC Press, 2007. http://dx.doi.org/10.3109/9781420061635.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders. Taylor & Francis Group, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Goldman, John M., and Tariq Mughal. Chronic Myeloproliferative Disorders. Taylor & Francis Group, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Mughal, Tariq, and John M. Goldman, eds. Chronic Myeloproliferative Disorders. CRC Press, 2013. http://dx.doi.org/10.3109/9780203091616.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Goldman, John M., and Tariq Mughal. Chronic Myeloproliferative Disorders. Taylor & Francis Group, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Chronic Myeloproliferative Disorders. Muenchen: Karger, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

(Editor), Tariq Mughal, and John M. Goldman (Editor), eds. Chronic Myeloproliferative Disorders. Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Bain, Barbara J. Chronic Myeloproliferative Disorders: Cytogenetic and Molecular Genetic Abnormalities (Chronic Myeloproliferative Disorders). S. Karger Publishers (USA), 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Myeloproliferative Disorders (Hematologic Malignancies). Springer, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

(Editor), J. V. Melo, and J. M. Goldman (Editor), eds. Myeloproliferative Disorders (Hematologic Malignancies). Springer, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Mughal, Tariq I., and Tiziano Barbui. Oxford Specialist Handbook: Myeloproliferative Neoplasms. Oxford University Press, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Mughal, Tariq I., and Tiziano Barbui, eds. Oxford Specialist Handbook: Myeloproliferative Neoplasms. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198744214.001.0001.

Full text
Abstract:
Our understanding of myeloproliferative neoplasms (MPN) disorders, a group of clonal haematological malignancies characterized by excessive accumulation of one or more myeloid cell lineages, has grown considerably over the past four decades. Even more importantly is the speed at which many of these findings were translated to accord survival benefits to our patients with MPN, in particular chronic myeloid leukaemia (CML), polycythaemia vera (PV), essential thrombocythaemia (ET), and primary myelofibrosis (PMF). This text offers a detailed evidence-based guide to MPN in an easily accessible format, structure to facilitate learning specialist information presenting core information in ‘bite size’ chunks. Each chapter summarizes the state-of-the art preclinical and clinical knowledge, and its impact on the clinical management of patients with MPN.
APA, Harvard, Vancouver, ISO, and other styles
40

Contemporary Management of Myeloproliferative Neoplasms. Jaypee Brothers Medical Publishers (P) Ltd., 2015. http://dx.doi.org/10.5005/jp/books/12391.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Tefferi, Ayalew, and Srdan Verstovsek. Myeloproliferative Neoplasms: Biology and Therapy. Humana, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Myeloproliferative disorders: Biology and management. New York, N.Y: Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Bennett, John M. Myeloproliferative Disorders: Biology and Management. Informa Healthcare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Tefferi, Ayalew, and Srdan Verstovsek. Myeloproliferative Neoplasms: Biology and Therapy. Humana Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Stein, Brady L., and Brandon J. McMahon. Contemporary Management of Myeloproliferative Neoplasms. Jaypee Brothers Medical Publishers, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Tefferi, Ayalew, and Tiziano Barbui. Myeloproliferative Neoplasms: Critical Concepts and Management. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography